Results 271 to 280 of about 12,522,600 (400)
Regional Lung Mechanics in Pulmonary Disease* [PDF]
, 1965 C. J. Martin, A. C. Young, Koh Ishikawa
openalex +1 more source
Arthritis Care &Research, Accepted Article.Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla +13 more
wiley +1 more source
Thoracic ultrasound in interstitial lung disease. [PDF]
Breathe (Sheff)Shah DJ +3 more
europepmc +1 more source
Inhalational Therapy For Chronic Lung Disease [PDF]
, 1962 Maurice S. Segal +2 more
openalex +1 more source
Arthritis Care &Research, Accepted Article.Objective We aimed to identify unique disease trajectories within rheumatoid arthritis‐associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999‐2021. RA‐ILD patients were
Bryant R. England +9 more
wiley +1 more source
Korean Guidelines for the Diagnosis and Management of Interstitial Lung Disease: Other Forms of Interstitial Lung Disease. [PDF]
Tuberc Respir Dis (Seoul)Kang HK +5 more
europepmc +1 more source
RIGHT VENTRICULAR HYPERTROPHY AND THE SMALL PULMONARY ARTERIES IN CHRONIC LUNG DISEASE [PDF]
, 1963 W. R. L. James, A. J. Thomas
openalex +1 more source
Chronic Opioids in Gout: A Matched Cohort Study from the Veteran's Health Administration
Arthritis Care &Research, Accepted Article.Objective Though used frequently to treat flare, risk of chronic opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed chronic opioids over time.
Lindsay N. Helget +7 more
wiley +1 more source